6487-38-3
Chemical Structure
3-Hydroxypropionic acid sodium
- CAS No.: 6487-38-3
- Formula:C3H5NaO3
- Molecular Weight:112.06
IUPAC Name: N-(3-(((S,Z)-3-(2-((1R,3aS,7aR,E)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexyl)oxy)propyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide
InChIKey: AVXDKPABPXSLIZ-UHFFFAOYSA-M
SMILES: O=C(CCO)O[Na]
Biological Activity: 3-Hydroxypropionic acid sodium is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid sodium exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid sodium can be used in studies related to nocturia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Hydroxypropionic acid sodium | 99.34% | 3-Hydroxypropionic acid sodium is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid sodium exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid sodium can be used in studies related to nocturia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Hydroxypropionic acid-13C3 sodium | 3-Hydroxypropionic acid-13C3 sodium is the 13C labeled 3-Hydroxypropionic acid sodium (HY-W095705A). 3-Hydroxypropionic acid sodium, an endogenous metabolite, is a building block in the chemical synthesis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Hydroxypropionic acid-d4 sodium | 98.0% | 3-Hydroxypropionic acid-d4 sodium is the deuterium labeled 3-Hydroxypropionic acid sodium (HY-W095705A). 3-Hydroxypropionic acid sodium, an endogenous metabolite, is a building block in the chemical synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Liang B, et al. Recent advances, challenges and metabolic engineering strategies in the biosynthesis of 3-hydroxypropionic acid. Biotechnology and bioengineering. 2022 Oct;119(10):2639-2668. [Content Brief]
- [2]. Kira S, et al. Urinary metabolites identified using metabolomic analysis as potential biomarkers of nocturia in elderly men. World journal of urology. 2020 Oct;38(10):2563-2569. [Content Brief]
